1
|
Amodru V, Garcia ME, Libe R, Brue T, Reznik Y, Castinetti F. Medical management of adrenocortical carcinoma: Current recommendations, new therapeutic options and future perspectives. Ann Endocrinol (Paris) 2020; 82:52-58. [PMID: 33279475 DOI: 10.1016/j.ando.2020.12.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/29/2020] [Accepted: 12/01/2020] [Indexed: 12/11/2022]
Abstract
Adrenocortical carcinoma is a rare malignant tumor of poor prognosis, frequently requiring additional treatments after initial surgery. Due to its adrenolytic action, mitotane has become the first-line medical treatment in patients with aggressive adrenocortical carcinoma. Over the last 2years, apart from the classical chemotherapy based on etoposide and platinum salts, several studies reported the use of drugs such as temozolomide, tyrosine kinase inhibitors or immunotherapy, with more or less convincing results. The aim of this review is to give further insights in the use of these drugs, and to describe potential therapeutic perspectives based on recent pangenomic studies, for the future management of these still difficult to treat tumors.
Collapse
Affiliation(s)
- Vincent Amodru
- Aix-Marseille University, Marseille Medical Genetics, INSERM, Department of endocrinology, La Conception Hospital, Marseille, France
| | - Marie-Eve Garcia
- Aix-Marseille University, Assistance publique-Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department, Marseille, France
| | - Rossella Libe
- Réseau National "ENDOCAN-COMETE-Cancers de la surrénale", Service d'Endocrinologie, Hôpital Cochin, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
| | - Thierry Brue
- Aix-Marseille University, Marseille Medical Genetics, INSERM, Department of endocrinology, La Conception Hospital, Marseille, France
| | - Yves Reznik
- Department of Endocrinology-Diabetology, Caen University Hospital, Caen, France
| | - Frederic Castinetti
- Aix-Marseille University, Marseille Medical Genetics, INSERM, Department of endocrinology, La Conception Hospital, Marseille, France.
| |
Collapse
|
2
|
Esnault H, Lahaye C, Girard L, Desoutter MA, Couvelard A, Alexandra JF, Faucher N, Raynaud-Simon A, Lilamand M, Sanchez M. [Bilateral adrenal tumors]. Rev Med Interne 2019; 41:62-64. [PMID: 31133331 DOI: 10.1016/j.revmed.2019.04.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2019] [Accepted: 04/23/2019] [Indexed: 11/25/2022]
Affiliation(s)
- H Esnault
- Département de gériatrie, hôpital universitaire Bichat, 46, rue Henri-Huchard, 75018 Paris, France
| | - C Lahaye
- Département de gériatrie, hôpital universitaire Bichat, 46, rue Henri-Huchard, 75018 Paris, France; Université Paris Diderot-Paris VII, Paris, France
| | - L Girard
- Département de gériatrie, hôpital universitaire Bichat, 46, rue Henri-Huchard, 75018 Paris, France
| | - M-A Desoutter
- Département de gériatrie, hôpital universitaire Bichat, 46, rue Henri-Huchard, 75018 Paris, France
| | - A Couvelard
- Département d'anatomo-pathologie, hôpital universitaire Bichat, Paris, France
| | - J-F Alexandra
- Département de médecine interne, hôpital universitaire Bichat, Paris, France
| | - N Faucher
- Département de gériatrie, hôpital universitaire Bichat, 46, rue Henri-Huchard, 75018 Paris, France
| | - A Raynaud-Simon
- Département de gériatrie, hôpital universitaire Bichat, 46, rue Henri-Huchard, 75018 Paris, France; Université Paris Diderot-Paris VII, Paris, France
| | - M Lilamand
- Département de gériatrie, hôpital universitaire Bichat, 46, rue Henri-Huchard, 75018 Paris, France; Université Paris Diderot-Paris VII, Paris, France
| | - M Sanchez
- Département de gériatrie, hôpital universitaire Bichat, 46, rue Henri-Huchard, 75018 Paris, France; Université Paris Diderot-Paris VII, Paris, France.
| |
Collapse
|
3
|
Espiard S, Benomar K, Loyer C, Vahé C, Vantyghem MC. European recommendations for the management of adrenal incidentalomas: A debate on patients follow-up. Ann Endocrinol (Paris) 2017; 79:45-48. [PMID: 29241951 DOI: 10.1016/j.ando.2017.08.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/12/2017] [Revised: 08/01/2017] [Accepted: 08/08/2017] [Indexed: 11/24/2022]
Affiliation(s)
- Stéphanie Espiard
- Service d'endocrinologie-métabolisme, hôpital C.-Huriez, CHRU de Lille, 59037 Lille, France.
| | - Kanza Benomar
- Service d'endocrinologie-métabolisme, hôpital C.-Huriez, CHRU de Lille, 59037 Lille, France
| | - Camille Loyer
- Service d'endocrinologie-métabolisme, hôpital C.-Huriez, CHRU de Lille, 59037 Lille, France
| | - Claire Vahé
- Service d'endocrinologie-métabolisme, hôpital C.-Huriez, CHRU de Lille, 59037 Lille, France
| | | |
Collapse
|
4
|
Dupic G, Biau J, Bellière-Calandry A, Lapeyre M. [Hypofractionated stereotactic body radiation therapy for adrenal metastases]. Cancer Radiother 2017; 21:404-410. [PMID: 28684242 DOI: 10.1016/j.canrad.2017.05.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2017] [Revised: 04/21/2017] [Accepted: 05/02/2017] [Indexed: 10/19/2022]
Abstract
Adrenal glands are a common site for metastatic spread since they represent the fourth metastatic site of solid tumors. Interest in local ablative treatments of oligometastases is growing since literature suggests better progression-free survival, quality of life and potentially overall survival in selected patients. Surgery remains the first treatment of adrenal oligometastases because results are good, with a long enough follow-up. However, stereotactic radiotherapy appears to be comparable to surgery and could be proposed to elderly, unfit, inoperable patients, or even to patients whose systemic treatment should not be suspended for too long. This article aims to present a review of published studies to date on stereotactic radiotherapy of adrenal metastases and to propose a treatment protocol.
Collapse
Affiliation(s)
- G Dupic
- Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France.
| | - J Biau
- Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - A Bellière-Calandry
- Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - M Lapeyre
- Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| |
Collapse
|